Lihong Huang

Dr. Lihong Huang

Cancer Center, ZhongShan Hospital, Fudan University, Shanghai, 200032, China ,
+1

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
JGJie Gu
Jie Gu
GYGuan-Min Yan
Guan-Min Yan
XKXiao-Lin Kong
Xiao-Lin Kong
YZYin-Ying Zhang
Yin-Ying Zhang
LHLihong Huang
Lihong Huang
HLHui-Min Lu
Hui-Min Lu

22 August 2025 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
YWYingying Wang
Yingying Wang
QJQijing Jiang
Qijing Jiang
XLXiaoyan Li
Xiaoyan Li
BRBichen Ren
Bichen Ren
BLBingzhe Li
Bingzhe Li
LHLihong Huang
Lihong Huang
Lipid metabolism-related inflammatory indices (LMIIs) have been recognized as potential biomarkers for the risks of atherosclerosis and major adverse cardiovascular events. This study aims to explore the associations of LMIIs, including neutrophil to high-density lipoprotein cholesterol ratio (NHR), monocyte to high-density lipoprotein cholesterol ratio (MHR), platelet to high-density lipoprotein cholesterol ratio (PHR), and lymphocyte to high-density lipoprotein cholesterol ratio (LHR), with the risk of incident peripheral artery disease (PAD) in elderly T2DM patients. A total of 2837 participants aged ≥ 60 years with T2DM from the Jinshan Cohort (China) and 13,542 participants from the UK Biobank (UK) were included in the primary analyses. According to the type of outcome variables, logistic regression models and Cox proportional-hazards models were used to estimate the risks of incident PAD associated with LMIIs. The methods of generalized propensity score (GPS), E-value and negative control exposure (NCE) were applied to control the potential confounding. Additionally, stratified analyses were performed across various populations to examine potential heterogeneity in the effects of LMIIs on PAD risk. Mediation effects of liver and kidney function-related indicators on associations between LMIIs and incident PAD were also explored. The results from traditional regression models suggested positive associations of incident PAD with all four LMIIs. In the Jinshan Cohort, the odds ratios (ORs) and 95% confidence intervals (CIs) of PAD for one-unit increase in NHR (109 mmol), MHR (108 mmol), PHR (1011 mmol) and LHR (109 mmol) were 1.24 (1.11–1.39), 1.22 (1.08–1.37), 1.69 (1.32–2.15) and 1.57 (1.22–2.01), respectively. While in the UK Biobank, the corresponding hazard ratios (HRs) and 95%CI were 1.14 (1.10–1.18), 1.03 (1.01–1.04), 1.19 (1.09–1.29) and 1.11 (1.07–1.14), respectively, These associations remained robust in regression models weighted by GPS methods. The E-values for the effects of each LMII on PAD were consistently found to be significantly larger than their corresponding observed effects in both cohorts. NCE analyses revealed no statistically significant associations between any selected NCE and PAD in either cohort. On calibration using NCEs, the calibrated P values confirmed significant effect sizes for associations between LMIIs and incident PAD (all for P < 0.05). Additionally, subgroup analyses in the Jinshan Cohort showed different associations varied across sex, residential area, smoking status and HbA1c level, with pronounced HRs in females, urban residents, smokers and individuals with HbA1c ≥ 7%. Findings from the UK Biobank further suggested that aspirin use and HbA1c level may modify the effects of LMIIs on PAD risk (P-interaction < 0.05). Mediation analyses indicated that estimated glomerular filtration rate (eGFR) mediated the relationships between LMIIs and PAD. The proportion of the mediating effects ranged from 10.03% to 19.95% in the Jinshan Cohort and from 10.20 to 20.80% in the UK Biobank. Elevated levels of LMIIs, such as NHR, MHR, PHR and LHR, were associated with an increased risk of incident PAD among elderly diabetic patients. These associations exhibited notable population heterogeneity, with stronger effects observed in females and individuals with higher HbA1c level. eGFR may serve as a mediating factor in the associations between LMIIs and the occurrence of PAD. These findings provide novel evidence for immune inflammation-based risk assessment and personalized preventive strategies for PAD.

27 December 2023 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PYPeilin Yu
Peilin Yu
ZJZhou Jiang
Zhou Jiang
CZChu Zheng
Chu Zheng
PZPing Zeng
Ping Zeng
LHLihong Huang
Lihong Huang
KWKe Wang
Ke Wang
Objectives: Adverse childhood experiences (ACEs) and anxiety-depression co-morbidity are attracting widespread attention. Previous studies have shown the relationship between individual psychiatric disorders and ACEs. This study will analyze the correlation between anxiety-depression co-morbidity and different levels of ACEs.Methods: Seven categories of ACE and four classifications of psychiatric disorders were defined in a sample of 126,064 participants identified by the UK Biobank from 2006–2022, and correlations were investigated using logistic regression models. Then, to explore nonlinear relationships, restricted spline models were developed to examine differences in sex and age across cohorts (n = 126,064 for the full cohort and n = 121,934 for the European cohort). Finally, the impact of the category of ACEs on psychiatric disorders was examined.Results: After controlling for confounders, ACEs scores showed dose-dependent relationships with depression, anxiety, anxiety-depression co-morbidity, and at least one (any of the first three outcomes) in all models. ACEs with different scores were significantly positively correlated with the four psychiatric disorders classifications, with the highest odds of anxiety-depression co-morbidity (odds ratio [OR] = 4.87, 95% confidence intervals [CI]: 4.37 ~ 5.43), p = 6.08 × 10−178. In the restricted cubic spline models, the risk was relatively flat for females at ACEs = 0–1 and males at ACEs = 0–2/3 (except in males, where ACEs were associated with a lower risk of anxiety, all other psychiatric disorders had an increased risk of morbidity after risk smoothing). In addition, the risk of having anxiety, depression, anxiety-depression co-morbidity, and at least one of these disorders varies with each category of ACEs.Conclusion: The prevalence of anxiety-depression comorbidity was highest across ACE scores after controlling for confounding factors and had a significant effect on each category of ACEs.

18 June 2021 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
XNXiaojian Ni
Xiaojian Ni
WWWenze Wan
Wenze Wan
JMJingjing Ma
Jingjing Ma
XLXinyou Liu
Xinyou Liu
BZBohao Zheng
Bohao Zheng
LHLihong Huang
Lihong Huang
Background: CD39 is one of the functional surface markers for T regulatory cells, the prognostic role and immune-related effects of CD39 in luminal breast cancer (BC) patients has not been evaluated yet. The aim of the current study was to explore the association between CD39 expression and clinic pathological characteristics and the prognosis in luminal BC patients.Methods: Clinical information and RNA-sequencing (RNA-Seq) expression data were extracted from The Cancer Genome Atlas (TCGA). Patients were divided into a high or low CD39 expression group by the optimal cutoff value (4.18) identified from the receiver operating characteristic curve analysis. The relationships between CD39 expression and clinic pathological features were evaluated by the corresponding statistical tests. Survival analyses were applied to evaluate the overall survival between the high and low CD39 expression groups in luminal BC. Furthermore, Gene Expression Omnibus datasets were used for external data validation. Gene set enrichment analysis (GSEA) was also performed, and CIBERSORT was used to analyze the immune cell populations.Results: Analysis of 439 cases of tumor data showed that CD39 was overexpressed in luminal BC. The multivariable analysis suggested that CD39 expression was an independent prognostic factor for luminal BC patients. GSEA suggested that CD39 might play an important role in luminal BC progression through immune regulation. Analysis of immune cell patterns revealed high CD39 expression correlated to a higher proportion of CD8+ T cells and M2 macrophages.Conclusion: This study demonstrates that CD39 expression correlates with the prognosis of luminal BC through TCGA database mining. Further studies are warranted further to elucidate this potential novel therapeutic strategy for BC.

22 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
YWYongyue Wei
Yongyue Wei
LWLiangmin Wei
Liangmin Wei
YLYihan Liu
Yihan Liu
LHLihong Huang
Lihong Huang
SSSipeng Shen
Sipeng Shen
FCFeng Chen
Feng Chen
Background: The incubation period of SARS-CoV-2 remains uncertain, which has important implications for estimating transmission potential, forecasting epidemic trends, and decision-making in prevention and control. Purpose: To estimate the central tendency and dispersion for incubation period of COVID-19 and, in turn, assess the effect of a certain length of quarantine for close contacts in active monitoring. Data Sources: PubMed, Embase, medRxiv, bioRxiv, and arXiv, searched up to April 26, 2020 Study Selection: COVID-19 studies that described either individual-level incubation period data or summarized statistics for central tendency and dispersion measures of incubation period were recruited. Data Extraction: From each recruited study, either individual-level incubation period data or summarized statistics for central tendency and dispersion measures were extracted, as well as population characteristics including sample size, average age, and male proportion. Data Synthesis: Fifty-six studies encompassing 4 095 cases were included in this meta-analysis. The estimated median incubation period for general transmissions was 5.8 days [95% confidence interval (95%CI), 5.3 to 6.2 d]. Median and dispersion were higher for SARS-CoV-2 incubation compared to other viral respiratory infections. Furthermore, about 20 in 10 000 contacts in active monitoring would develop symptoms after 14 days, or below 1 in 10 000 for young-age infections or asymptomatic transmissions. Limitation: Small sample sizes for subgroups; some data were possibly used repeatedly in different studies; limited studies for outside mainland China; non-negligible intra-study heterogeneity. Conclusion: The long, dispersive incubation period of SARS-CoV-2 contributes to the global spread of COVID-19. Yet, a 14-day quarantine period is sufficient to trace and identify symptomatic infections, which while could be justified according to a better understanding of the crucial parameters.

9 October 2023 in Emerging Microbes & Infections
Verified
Journal Article
Open access
MLMengna Lin
Mengna Lin
KCKangli Cao
Kangli Cao
FXFeixiang Xu
Feixiang Xu
XWXueling Wu
Xueling Wu
YSYao Shen
Yao Shen
ZSZhenju Song
Zhenju Song
Limited follow-up data is available on the recovery of Omicron COVID-19 patients after acute illness. It is also critical to understand persistence of neutralizing antibody (NAb) and of T-cell mediated immunity and the role of hybrid immunity in preventing SARS-CoV-2 reinfection. This prospective cohort study included Omicron COVID-19 individuals from April to June 2022 in Shanghai, China, during a large epidemic caused by the Omicron BA.2 variant. A total of 8945 patients from three medical centres were included in the follow up programme from November 2022 to February 2023. Of 6412 individuals enrolled for the long COVID analysis, 605 (9.4%) individuals experienced at least one sequelae, mainly had fatigue and mental symptoms specific to Omicron BA.2 infection compared with other common respiratory tract infections. During the second-visit, 548 (12.1%) cases of Omicron reinfection were identified. Hybrid immunity with full and booster vaccination had reduced risk of SARS-CoV-2 reinfection by 0.29-fold (95% CI: 0.63-0.81) and 0.23-fold (95% CI: 0.68-0.87), respectively. For 469 participants willing to the hospital during the first visit, those who received full (72 [IQR, 36-156]) or booster (64 [IQR, 28-132]) vaccination had significantly higher neutralizing antibody titers than those with incomplete vaccination (36 [IQR, 16-79]). Moreover, non-reinfection cases had higher neutralizing antibody titers (64 [IQR, 28-152]) compared to reinfection cases (32 [IQR, 20-69]).